NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $589,000 | -16.1% | 33,010 | +1.5% | 0.02% | -17.4% |
Q4 2019 | $702,000 | +663.0% | 32,510 | +540.0% | 0.02% | +475.0% |
Q3 2019 | $92,000 | -49.2% | 5,080 | 0.0% | 0.00% | -69.2% |
Q2 2019 | $181,000 | +64.5% | 5,080 | +54.9% | 0.01% | +85.7% |
Q1 2019 | $110,000 | -39.9% | 3,280 | -41.2% | 0.01% | -36.4% |
Q4 2018 | $183,000 | -11.2% | 5,580 | +32.2% | 0.01% | 0.0% |
Q2 2018 | $206,000 | -54.0% | 4,220 | 0.0% | 0.01% | -50.0% |
Q1 2018 | $448,000 | -87.3% | 4,220 | -92.9% | 0.02% | -87.6% |
Q4 2017 | $3,534,000 | +150.3% | 59,170 | +0.6% | 0.18% | +136.0% |
Q3 2017 | $1,412,000 | +96.9% | 58,840 | +60.5% | 0.08% | +108.3% |
Q2 2017 | $717,000 | -12.6% | 36,660 | +5.0% | 0.04% | -7.7% |
Q1 2017 | $820,000 | +94.8% | 34,920 | +1.7% | 0.04% | +95.0% |
Q4 2016 | $421,000 | -19.0% | 34,350 | +13.6% | 0.02% | -25.9% |
Q3 2016 | $520,000 | +22.9% | 30,250 | +1.6% | 0.03% | +17.4% |
Q2 2016 | $423,000 | +6.0% | 29,760 | +2.5% | 0.02% | -14.8% |
Q1 2016 | $399,000 | -11.5% | 29,020 | +8.3% | 0.03% | -18.2% |
Q4 2015 | $451,000 | +56.1% | 26,790 | +1.6% | 0.03% | +200.0% |
Q3 2015 | $289,000 | – | 26,380 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |